ISPE announced its inaugural Pharmaceutical Serialization Workshops, taking place 8 – 9 May in Philadelphia, Pennsylvania USA. This unique event combines the benefits of a conference experience with ten interactive workshops covering baseline as well as advanced issues focused on the conference theme "Leveraging Operations to Maximize Supply Chain Performance".
“Given the degree of complexity involved with serialization, it demands an understanding from the shop floor through enterprise-wide systems to mitigate risks, ensure data interconnectivity across the supply chain, reduce and address defects, and ensure quality control,” said John Bournas, ISPE CEO and President. “This event was designed to offer insights for a broad spectrum of industry professionals, providing systemic approaches and essential strategies along with valuable case studies addressing key questions facing the industry.”
This interactive conference features a diversity of global experts who have been working effectively on track-and-trace and serialization implementation issues for years, including:
In addition to the ten workshops, this event offers four engaging general sessions, including two industry discussion panels and two keynote sessions.
Learn more about the 2017 Pharmaceutical Serialization Workshops and register today!
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...
